← Back to Patent Explorer
US4431582A Expired / Lapsed US ⏱️ 0.0 years remaining

Protein, composition and method for enhancing epithelial cell movement

Assignee: Research Corp
•
Filing: 1982-12-17
•
Granted: 1984-02-14
•
Expires: 2002-12-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A protein has been isolated from mammalian plasma or serum which enhances epithelial cell movement. A second factor which has no epithelial cell movement activity has also been isolated from mammalian plasma or serum which, when combined with the first protein, enhances the epithelial cell movement activity thereof.

Inventors

  • 👤 Kurt S. Stenn

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 17:51
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/46; C07K14/47; C07K14/4701; C07K14/4702; C07K14/4705; C07K16/00; C07K16/18; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/829; Y10S530/83

Claims Analysis

Total Claims: 6
Claim 1
Independent Claim 199 words
A trypsin digestible single-chained, glycosylated protein which enhances epithelial cell movement in vivo having the following properties: (a) a molecular weight of about 62,000 daltons; (b) resistant to serine protease inhibitors, diisopropyl fluorophosphate and phenyl methyl sulfonyl fluoride; (c) isoelectric point between 5.1 and 5.2; (d) extinction coefficient of about 1.0 at 280 nm ultraviolet light, and (e) an amino acid composition including but not limited to: ______________________________________ No. of amino acids No. of amino acid Amino per protein molecule molecules per 1000 Acid 62,752 daltons amino acids ______________________________________ Asp 62 111 Thr 40 72 Ser 46 81 Glu 67 119 Pro 19 35 Gly 26 46 Ala 43 77 Val 33 59 Met 15 26 Ile 24 44 Leu 69 123 Tyr 12 22 Phe 31 56 His 12 21 Lys 34 60 Arg 21 37 Trp 4 7 Cys 2 4; ______________________________________ (f) the N-terminal amino acid is asparagine and the N-terminal amino acid sequence is NH 2 -Asparagine-serine-proline-leucine-aspartic-glutamic; (g) immunoelectrophoresis properties of a serum α 2 globulin; (h) antibody to the protein blocks all the epidermal cell spreading activity of human serum; (i) antibody to the protein does not react with other known human serum proteins.
Claim 2
Dependent Claim 199 words
A trypsin digestible single-chained, glycosylated protein which enhances epithelial cell movement in vivo having the following properties: (a) a molecular weight of about 62,000 daltons; (b) resistant to serine protease inhibitors, diisopropyl fluorophosphate and phenyl methyl sulfonyl fluoride; (c) isoelectric point between 5.1 and 5.2; (d) extinction coefficient of about 1.0 at 280 nm ultraviolet light, and (e) an amino acid composition including but not limited to: ______________________________________ No. of amino acids No. of amino acid Amino per protein molecule molecules per 1000 Acid 62,752 daltons amino acids ______________________________________ Asp 62 111 Thr 40 72 Ser 46 81 Glu 67 119 Pro 19 35 Gly 26 46 Ala 43 77 Val 33 59 Met 15 26 Ile 24 44 Leu 69 123 Tyr 12 22 Phe 31 56 His 12 21 Lys 34 60 Arg 21 37 Trp 4 7 Cys 2 4; ______________________________________ (f) the N-terminal amino acid is asparagine and the N-terminal amino acid sequence is NH 2 -Asparagine-serine-proline-leucine-aspartic-glutamic; (g) immunoelectrophoresis properties of a serum α 2 globulin; (h) antibody to the protein blocks all the epidermal cell spreading activity of human serum; (i) antibody to the protein does not react with other known human serum proteins.
Claim 3
Dependent Claim 177 words
A method of preparing the protein of claim 1 comprising: (1) diluting mammalian plasma or serum with water and dissolving therein sufficient ammonium sulfate to produce an approximately 33.3% saturated solution and removing the thus formed precipitate; (2) dissolving in the solution remaining from step (1) sufficient ammonium sulfate to produce an approximately 66.7% saturated solution; (3) removing the precipitate from the solution produced by step (2), suspending it in water and dialyzing the suspension against a buffered solution having a pH of about 6.0; (4) placing the dialyzed fraction in a buffered solution having a pH of about 6.0 and subjecting the solution to anionic chromatographic separation, including washing the chromatographically adhered fraction with said buffered solution; (5) eluting the chromatographically adhered fraction with a buffered solution having a pH of about 6.0 and an anionic strength of about 12 mmhos; (6) dialyzing the eluted fraction against a buffered solution having a pH of about 6.0; and (7) subjecting the dialysand to isoelectric precipitation at a pH of between 4.6 and 5.0 to produce the protein.
Claim 4
Dependent Claim 17 words
The method of claim 2 wherein said protein is further purified by gel filtration chromatography and electrophoresis.
Claim 5
Dependent Claim 127 words
A method of preparing a factor which enhances the epithelial cell movement activity of the protein of claim 2 comprising; (1) diluting mammalian plasma or serum with water and dissolving therein sufficient ammonium sulfate to produce an approximately 33.3% saturated solution and removing the thus formed precipitate; (2) dissolving in the solution remaining from step (1) sufficient ammonium sulfate to produce an approximately 66.7% saturated solution; (3) removing the precipitate from the solution produced by step (2), suspending it in water and dialyzing the suspension against a buffered solution having a pH of about 6.0; (4) placing the dialyzed fraction in a buffered solution having a pH of about 6.0 and subjecting the solution to anionic chromatographic separation, collecting the chromatographically non-adhered fraction with said buffered solution.
Claim 6
Dependent Claim 5 words
The product of claim 4.

References Cited (Backward Citations)

US3973001A Cited
US3122476A Cited
US3948875A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1987-02-13 1987-08-15 1988-02-14 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1991-02-13 1991-08-15 1992-02-14 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1995-02-13 1995-08-15 1996-02-14 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag